Temazepam and Unilateral hydronephrosis - a phase IV clinical study of FDA data

Summary:

Unilateral hydronephrosis is reported as a side effect among people who take Temazepam (temazepam), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Zometa, and have Pain.

The phase IV clinical study analyzes which people have Unilateral hydronephrosis when taking Temazepam. It is created by eHealthMe based on reports of 40,724 people who have side effects when taking Temazepam from the FDA, and is updated regularly.

What is Temazepam?

Temazepam has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,106 Temazepam users. Check the latest studies of Temazepam.

What is Unilateral hydronephrosis?

Unilateral hydronephrosis (kidney stone that causes obstruction of the ureter) is found to be associated with 1,010 drugs and 1,192 conditions by eHealthMe. Check the latest studies of Unilateral hydronephrosis.

On Jul, 12, 2026

40,724 people reported to have side effects when taking Temazepam.
Among them, 62 people (0.15%) have Unilateral hydronephrosis.

Could Temazepam cause Unilateral hydronephrosis?

Among these 62 people:

How long have people been on Temazepam when they have Unilateral hydronephrosis? *

What is the gender of people who have Unilateral hydronephrosis when taking Temazepam? *

female: 48.39 %
male: 51.61 %

What is the age of people who have Unilateral hydronephrosis when taking Temazepam? *

What are other drugs people take besides Temazepam? *

What are other side effects people have besides Unilateral hydronephrosis? *

Pain: 32 people, 51.61%
Osteonecrosis Of Jaw (death of bone of jaw): 28 people, 45.16%
Stress And Anxiety: 26 people, 41.94%
Nausea And Vomiting: 26 people, 41.94%
Joint Pain: 24 people, 38.71%
Anaemia (lack of blood): 24 people, 38.71%
Dehydration (dryness resulting from the removal of water): 23 people, 37.10%
Ureteric Obstruction: 23 people, 37.10%
Fatigue (feeling of tiredness): 22 people, 35.48%
Metastases To Bone (cancer spreads to bone): 22 people, 35.48%

What are the existing conditions these people have? *

Pain: 21 people, 33.87%
Metastases To Bone (cancer spreads to bone): 13 people, 20.97%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 13 people, 20.97%
High Blood Pressure: 8 people, 12.90%
Indigestion: 8 people, 12.90%
Nervousness: 8 people, 12.90%
Depression: 6 people, 9.68%
Constipation: 4 people, 6.45%
Stress And Anxiety: 4 people, 6.45%
Back Pain: 4 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Temazepam and have Unilateral hydronephrosis?

- Check whether Unilateral hydronephrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Temazepam:

Temazepam (42,106 reports)

Browse all side effects of Temazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Unilateral hydronephrosis:

Unilateral hydronephrosis (1,010 drugs)

Browse all the conditions that are associated with Unilateral hydronephrosis:

Unilateral hydronephrosis (1,192 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on temazepam (the active ingredients of Temazepam) and Temazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.